February 2021

CAP Loses Accreditation Clients to Joint Commission

CEO SUMMARY: Over the past 18 months, several prominent national health systems decided to shift their CLIA laboratory accreditation services away from the College of American Pathologists and to The Joint Commission. These shifts from one accrediting body to another will involve hundreds of hospital laboratories. Such a shift in the market for CLIA accreditation …

CAP Loses Accreditation Clients to Joint Commission Read More »

To access this post, you must purchase The Dark Report.

Clinical Labs Have the Opportunity to Deliver Value

FOR DECADES, PATHOLOGISTS AND CLINICAL LABORATORY PROFESSIONALS have called attention to the single most powerful resource possessed by theirĀ lab organizations: patient lab test data. Everyone in lab medicine is familiar with the oft-repeated statement thatĀ the cost of lab testing is about 3Ā¢ to 5Ā¢ on the healthcare dollar, but lab testĀ data is involved in 60% …

Clinical Labs Have the Opportunity to Deliver Value Read More »

To access this post, you must purchase The Dark Report.

What’s Ahead for Labs? It’ll Be Quite Different

CEO SUMMARY: In many ways, the nation’s clinical laboratoriesĀ performed magnificently in response to the SARS-CoV-2Ā outbreak last winter. But that magnificent performance has takenĀ its toll on the infrastructure and personnel within these labs. TheĀ Dark Report provides insights into four key factors common toĀ all clinical laboratories, particularly those that currently performĀ large numbers of COVID-19 tests. The following …

What’s Ahead for Labs? It’ll Be Quite Different Read More »

To access this post, you must purchase The Dark Report.

Academic, Commercial Collaboration for Testing

CEO SUMMARY: In several important ways, this collaborationĀ involving an academic clinical laboratory and a commercial companyĀ has paid big dividends, not just for the two partners, but alsoĀ the parent university that oversaw the project. The two partnersĀ developed a SARS-CoV-2 test, then manufactured it in large quantities.Ā The molecular COVID-19 test, named Clarifi, uses a salivaĀ specimen and has …

Academic, Commercial Collaboration for Testing Read More »

To access this post, you must purchase The Dark Report.

SARS-CoV-2 Variant Sequencing Creates New Opportunities for Labs

This is an excerpt of a 2,964-word article in the February 8, 2021 issue of Ā THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: Variants of the COVID-19 virus are appearing across the world. Recent data show the same variants will infect peopleĀ in several different countries. …

SARS-CoV-2 Variant Sequencing Creates New Opportunities for Labs Read More »

To access this post, you must purchase The Dark Report.

Critics Say New At-Home Test Is Expensive and Late to Market

ONCE AGAIN, THE COMBINATION of the pandemic and the federal governmentĀ may be creating a credibleĀ new competitor in the in vitro diagnosticsĀ (IVD) industry. This time, the lucky companyĀ is Ellume, which was just awardedĀ $231.8 million from the Biden administrationĀ to scale up production of a home testĀ for SARS-CoV-2. Ellume was given an emergency-useĀ authorization (EUA) from the federalĀ Food and …

Critics Say New At-Home Test Is Expensive and Late to Market Read More »

To access this post, you must purchase The Dark Report.

Variant Sequencing of SARS-CoV-2 Creates Opportunities for Labs

CEO SUMMARY: Variants of the COVID-19 virus are appearing across the world. Recent data show the same variants will infect peopleĀ in several different countries. Here in the United States, interestĀ is growing in having clinical laboratories sequence specimens fromĀ patients who test positive as a way to identify mutations and track theirĀ spread. Today, there is no reimbursement …

Variant Sequencing of SARS-CoV-2 Creates Opportunities for Labs Read More »

To access this post, you must purchase The Dark Report.

Proscia Lands Major Deals as Digital Pathology Demand Grows

EVEN AS THE WORLDWIDE COVID-19 PANDEMIC DERAILED SOME INDUSTRIES, it gave a major boost to digitalĀ pathology. That has meant an expandingĀ market for Proscia, a seven-year-old providerĀ of digital and computational pathologyĀ solutions. Established in 2014, Proscia recentlyĀ won what may be the world’s most importantĀ contract involving digital pathologyĀ and computational pathology solutions. On Oct. 20, 2020, it was announced …

Proscia Lands Major Deals as Digital Pathology Demand Grows Read More »

To access this post, you must purchase The Dark Report.

hc1, Visiun, and Viewics: Analytics Market Evolves

CEO SUMMARY: To understand any development in theĀ marketplace, it is best to follow the money. That Roche, QuestĀ Diagnostics, and LabCorp spent money either to purchase orĀ partner with a lab analytics company in the past 36 months indicatesĀ that these enterprises believe acquiring or working withĀ lab analytics systems can deliver competitive advantage. LabsĀ began showing interest in real-time …

hc1, Visiun, and Viewics: Analytics Market Evolves Read More »

To access this post, you must purchase The Dark Report.

February 8, 2021 Intelligence: Late-Breaking Lab News

Pathologists and clinicalĀ lab managers withĀ an entrepreneurial yenĀ will be interested to knowĀ that Anthem, Inc., whichĀ serves 43 million beneficiaries,Ā has launched a digital incubator.Ā The new initiative wasĀ announced last month. FierceĀ Healthcare reported that theĀ Anthem Digital IncubatorĀ (ADI) will ā€œpair financial backingĀ with mentorship andĀ opportunities for partnershipsĀ with universities and others.ā€ MORE ON: Anthem DI News reports say that ADIĀ is accepting applications forĀ community …

February 8, 2021 Intelligence: Late-Breaking Lab News Read More »

To access this post, you must purchase The Dark Report.

;